The Key We Are Overlooking in Peripheral Vascular Disease

To change the prognosis of peripheral vascular disease patients, a referral for supervised exercise is paramount. This should be a cultural change, not only an individual recommendation.

ejercicio y enfermedad vascular periférica

A physically active lifestyle reduces the risk of cardiovascular events and functional impairment in patients with peripheral vascular disease.

The novelty of this work (forthcoming in Eur J Vasc Endovasc Surg) is that it compares physical activity patterns from peripheral vascular disease patients in two countries: one presenting an epidemic of sedentary and overweight individuals (United Stated) and another that actively promotes physical activity as a public health policy (the Netherlands).

Patients self-reported their physical activity following a binary classification (sedentarism or physical activity), with follow-up at 3, 6, and 12 months.

Participants were registered in the Patient-centered Outcomes Related to Treatment Practices in Peripheral Arterial Disease: Investigating Trajectories (PORTRAIT) registry, which included patients with new or worsening intermittent claudication.

This study included a total of 1098 patients: 743 recruited in the US (67.7%) and 355 in the Netherlands (32.3%).


Read also: What Is the Healthiest Diet?


American patients were older (mean age: 68.6 years vs. 65.3 years; p < 0.001) and heavier (41.3% vs. 20.5%; p < 0.001), but fewer were smokers (30.1% vs. 52.8%; p < 0.001) and more were female (41.3% vs. 31.4%; p = 0.002).

The main difference between countries was the patients’ supervised exercise baseline (1.6% in the US vs. 63.9% in the Netherlands; p < 0.001). Not only were Americans more sedentary at baseline, but also only a small percentage of them were formally instructed to exercise in a supervised manner.

Conclusion

To change the prognosis of symptomatic peripheral vascular disease patients, a referral for supervised exercise is paramount. Advising them to walk moreis not enough: a cultural change must take place.

Original Title: Physical Activity in Patients with Symptomatic Peripheral Artery Disease: Insights from the PORTRAIT Registry.

Reference: Poghni A. Peri-Okonny et al. Eur J Vasc Endovasc Surg. 2020 Jul 21;S1078-5884(20)30528-1. https://doi.org/10.1016/j.ejvs.2020.06.010.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC 2026 | HI-PEITHO: Catheter-directed strategy (EKOS) in intermediate-risk acute pulmonary embolism

The treatment of intermediate-risk pulmonary embolism (PE) continues to be an area of therapeutic uncertainty. The initial PEITHO study (2014) demonstrated a reduction in...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

FFR Assessment for the Selection of Hypertensive Patients Who Benefit from Renal Stenting

Atherosclerotic renal artery stenosis (ARAS) represents one of the main causes of secondary hypertension (HTN) and is associated with a higher risk of renal...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

Ischemic stroke remains one of the most feared complications of TAVI, with a relatively low but persistent incidence of 2–4%, without significant reduction over...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...